Form 4: Medpace Holdings Executive Acquires Stock Options
SEC Form 4 Filing
Stephen P. Ewald, General Counsel & Corp. Secy. of Medpace Holdings, Inc., reports acquisition of stock options.
Summary
- Stephen P. Ewald, General Counsel & Corp. Secy. of Medpace Holdings, Inc., filed a Form 4 on March 10, 2025.
- The report details the acquisition of 6,591 employee stock options with an exercise price of $325.73 on March 6, 2025.
- These options vest on the fifth anniversary of the grant date (March 6, 2030), contingent upon continued employment.
- Ewald also directly owns 13,343 shares of Medpace Holdings, Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, indicating a neutral sentiment.
Future Outlook
The vesting of the options is contingent upon the Reporting Person's continued employment with the Issuer or one of its subsidiaries.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The acquisition of stock options aligns the executive's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/06/2025 | Date of earliest transaction: acquisition of stock options. |
| 03/06/2025 | Date of stock option grant. |
| 03/06/2032 | Expiration date of stock options. |
| 03/10/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.